CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 2.62: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.29%Below 5Y avg (2.38%)
Annual Rate
EUR 0.02Paid unknown
Payout Ratio
68.5%Moderate
Paying Dividends
10 yr
Last Ex-Dividend
Jul 20, 2026
Last Payment
Nov 8, 1995
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
267.10MEUR312.04M · vs all stocks (USD)
Trailing P/E
52.20xRevenue (TTM)
64.53MEUR75.39M · vs all stocks (USD)
Profit Margin
8.02%Beta
1.00xvs all stocks
52-Week Change
82.50%vs all stocks
Forward Annual Dividend Yield
1.29%vs all stocks
Market Capitalization
267.10MEUR312.04M · vs all stocks (USD)
Enterprise Value
289.02MEUR337.65M · vs all stocks (USD)
Trailing P/E
52.20xPrice to Sales (TTM)
4.14xPrice to Book (MRQ)
4.69xEnterprise to Revenue
4.48xEnterprise to EBITDA
21.73xProfit Margin
8.02%Operating Margin
12.49%Return on Assets (TTM)
4.60%Return on Equity (TTM)
10.61%Revenue (TTM)
64.53MEUR75.39M · vs all stocks (USD)
Revenue per Share (TTM)
0.3820EURUpdated Aug 21, 2026Quarterly Revenue Growth
15.40%Gross Profit (TTM)
30.86MEUR36.05M · vs all stocks (USD)
EBITDA (TTM)
14.37MEUR16.79M · vs all stocks (USD)
Net Income (TTM)
5.18MEUR6.05M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-49.70%Operating Cash Flow (TTM)
6.67MEUR7.79M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
5.99MEUR6.99M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0200EURUpdated Aug 21, 2026Forward Annual Dividend Yield
1.29%vs all stocks
Trailing Annual Dividend Rate
0.00EURUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
5-Year Average Dividend Yield
2.38%vs all stocks
Payout Ratio
68.49%Minority Interest (Equity)
-7.00KEURFY2025 · Dec 31, 2025Revenue
62.58MEURFY2025 · Dec 31, 2025Cost of Goods Sold
32.28MEURFY2025 · Dec 31, 2025Gross Profit
30.30MEURFY2025 · Dec 31, 2025Operating Income
9.01MEUR10.52M · vs all stocks (USD)
Pre-tax Income
7.50MEURFY2025 · Dec 31, 2025Income Tax Expense
2.45MEURFY2025 · Dec 31, 2025Net Income
5.99MEURFY2025 · Dec 31, 2025EBIT
9.34MEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
14.37MEURFY2025 · Dec 31, 2025Research & Development
344.00KEURFY2025 · Dec 31, 2025Selling, General & Administrative
11.30MEURFY2025 · Dec 31, 2025Other Operating Expenses
736.00KEURFY2025 · Dec 31, 2025Non-operating Interest Income
56.00KEURFY2025 · Dec 31, 2025Non-operating Interest Expense
1.84MEURFY2025 · Dec 31, 2025EPS (Basic)
0.0356EURFY2025 · Dec 31, 2025EPS (Diluted)
0.0346EURFY2025 · Dec 31, 2025Basic Shares Outstanding
168.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
168.40MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.00KEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
1.74MEURFY2025 · Dec 31, 2025Free Cash Flow
-2.76MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.11MEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
7.50MEURFY2025 · Dec 31, 2025Other Non-cash Items
2.81MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.72MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.86MEURFY2025 · Dec 31, 2025Capital Expenditures
-4.50MEURFY2025 · Dec 31, 2025Net Acquisitions
0.00EURFY2025 · Dec 31, 2025Other Investing Activity
1.41MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.09MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
40.16MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-42.34MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-200.00KEURFY2025 · Dec 31, 2025Common Dividends Paid
-3.38MEURFY2025 · Dec 31, 2025Other Financing Charges
1.68MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-4.09MEURFY2025 · Dec 31, 2025Shares Outstanding
169.04MSharesUpdated Aug 21, 2026% Held by Insiders
61.09%vs all stocks
% Held by Institutions
1.04%vs all stocks
Total Cash (MRQ)
6.11MEUR7.13M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0360EURUpdated Aug 21, 2026Total Debt (MRQ)
32.78MEUR38.29M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5810xCurrent Ratio (MRQ)
1.21xBook Value per Share (MRQ)
0.3340EURUpdated Aug 21, 2026Total Assets
130.22MEUR152.13M · vs all stocks (USD)
Total Current Assets
53.20MEURFY2025 · Dec 31, 2025Total Liabilities
73.81MEURFY2025 · Dec 31, 2025Total Non-current Assets
77.03MEURFY2025 · Dec 31, 2025Total Non-current Liabilities
29.83MEURFY2025 · Dec 31, 2025Total Current Liabilities
43.98MEURFY2025 · Dec 31, 2025Cash
3.00KEURFY2025 · Dec 31, 2025Cash Equivalents
6.10MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
6.11MEURFY2025 · Dec 31, 2025Accounts Receivable
20.29MEURFY2025 · Dec 31, 2025Inventory
22.61MEURFY2025 · Dec 31, 2025Accounts Payable
9.86MEURFY2025 · Dec 31, 2025Short-term Debt
11.84MEURFY2025 · Dec 31, 2025Other Current Liabilities
-2.00KEURFY2025 · Dec 31, 2025Long-term Debt
20.83MEURFY2025 · Dec 31, 2025Other Non-current Liabilities
1.55MEURFY2025 · Dec 31, 2025Common Stock (Book)
50.71MEURFY2025 · Dec 31, 2025Retained Earnings
-21.67MEURFY2025 · Dec 31, 2025Total Shareholders' Equity
56.41MEUR65.91M · vs all stocks (USD)
52-Week Low
0.7560EURUpdated Aug 21, 202652-Week High
1.74EURUpdated Aug 21, 202652-Week Change
82.50%vs all stocks
Beta
1.00xvs all stocks
50-Day MA
1.54EURUpdated Aug 21, 2026200-Day MA
1.28EURUpdated Aug 21, 2026Avg 10-Day Volume
21.03KSharesUpdated Aug 21, 2026Avg 30-Day Volume
59.84KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.0300EURUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.62: safe zoneNotable
Altman Z-Score: 2.62
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Won Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Solara Active Pharma Sciences Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guiyang Xintian Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
AP Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Eledon Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Allgens Medical Technology Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Il Dong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Animalcare Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Medy-Tox Inc.
Tier 1ProductionApproval-Gated PipelineRule
Santhera Pharmaceuticals Holding AG
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Regeneron Pharmaceuticals, Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
XPEL, Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
FNCL Series 2007 Other Floating Rate Instrument
1 interpretationMulti-Year Revenue, Profit, And Income Growth